nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—prostate gland—urinary bladder cancer	0.0738	0.258	CbGeAlD
Icosapent ethyl—DGAT1—seminal vesicle—urinary bladder cancer	0.0624	0.218	CbGeAlD
Icosapent ethyl—DGAT1—urethra—urinary bladder cancer	0.0494	0.173	CbGeAlD
Icosapent ethyl—DGAT1—female reproductive system—urinary bladder cancer	0.0403	0.141	CbGeAlD
Icosapent ethyl—DGAT1—vagina—urinary bladder cancer	0.0364	0.127	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—urinary bladder cancer	0.0236	0.0824	CbGeAlD
Icosapent ethyl—Icosapent—TRPV1—urinary bladder cancer	0.0152	0.381	CrCbGaD
Icosapent ethyl—Alpha-Linolenic Acid—TRPV1—urinary bladder cancer	0.0148	0.372	CrCbGaD
Icosapent ethyl—Icosapent—PPARG—urinary bladder cancer	0.00504	0.126	CrCbGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—urinary bladder cancer	0.00271	0.068	CrCbGaD
Icosapent ethyl—Icosapent—PTGS2—urinary bladder cancer	0.00213	0.0534	CrCbGaD
Icosapent ethyl—Tachycardia—Fluorouracil—urinary bladder cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—urinary bladder cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—urinary bladder cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—urinary bladder cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Anorexia—Gemcitabine—urinary bladder cancer	0.00105	0.00156	CcSEcCtD
Icosapent ethyl—Malaise—Etoposide—urinary bladder cancer	0.00104	0.00155	CcSEcCtD
Icosapent ethyl—Vertigo—Etoposide—urinary bladder cancer	0.00104	0.00154	CcSEcCtD
Icosapent ethyl—Body temperature increased—Thiotepa—urinary bladder cancer	0.00104	0.00154	CcSEcCtD
Icosapent ethyl—Anorexia—Fluorouracil—urinary bladder cancer	0.00104	0.00154	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00103	0.00153	CcSEcCtD
Icosapent ethyl—Oedema—Cisplatin—urinary bladder cancer	0.00103	0.00153	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00102	0.00152	CcSEcCtD
Icosapent ethyl—Infection—Cisplatin—urinary bladder cancer	0.00102	0.00152	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—urinary bladder cancer	0.00102	0.00151	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Etoposide—urinary bladder cancer	0.00102	0.00151	CcSEcCtD
Icosapent ethyl—Cough—Etoposide—urinary bladder cancer	0.00101	0.0015	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00101	0.00149	CcSEcCtD
Icosapent ethyl—Tachycardia—Cisplatin—urinary bladder cancer	0.00101	0.00149	CcSEcCtD
Icosapent ethyl—Insomnia—Gemcitabine—urinary bladder cancer	0.000999	0.00148	CcSEcCtD
Icosapent ethyl—Hypertension—Etoposide—urinary bladder cancer	0.000998	0.00148	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000996	0.00148	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—urinary bladder cancer	0.000994	0.00147	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00099	0.00147	CcSEcCtD
Icosapent ethyl—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000985	0.00146	CcSEcCtD
Icosapent ethyl—Chest pain—Etoposide—urinary bladder cancer	0.000984	0.00146	CcSEcCtD
Icosapent ethyl—Insomnia—Fluorouracil—urinary bladder cancer	0.000983	0.00146	CcSEcCtD
Icosapent ethyl—Anorexia—Cisplatin—urinary bladder cancer	0.000982	0.00146	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—urinary bladder cancer	0.00098	0.00145	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—urinary bladder cancer	0.00098	0.00145	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—urinary bladder cancer	0.000974	0.00145	CcSEcCtD
Icosapent ethyl—Discomfort—Etoposide—urinary bladder cancer	0.000972	0.00144	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000969	0.00144	CcSEcCtD
Icosapent ethyl—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000969	0.00144	CcSEcCtD
Icosapent ethyl—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00096	0.00142	CcSEcCtD
Icosapent ethyl—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000956	0.00142	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000954	0.00141	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—urinary bladder cancer	0.000952	0.00141	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000949	0.00141	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000947	0.0014	CcSEcCtD
Icosapent ethyl—Constipation—Gemcitabine—urinary bladder cancer	0.000945	0.0014	CcSEcCtD
Icosapent ethyl—Pain—Gemcitabine—urinary bladder cancer	0.000945	0.0014	CcSEcCtD
Icosapent ethyl—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000944	0.0014	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000943	0.0014	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—urinary bladder cancer	0.000943	0.0014	CcSEcCtD
Icosapent ethyl—Asthenia—Thiotepa—urinary bladder cancer	0.000942	0.0014	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000938	0.00139	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000938	0.00139	CcSEcCtD
Icosapent ethyl—Infection—Etoposide—urinary bladder cancer	0.000937	0.00139	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—urinary bladder cancer	0.000936	0.00139	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—urinary bladder cancer	0.00093	0.00138	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—urinary bladder cancer	0.00093	0.00138	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—urinary bladder cancer	0.00093	0.00138	CcSEcCtD
Icosapent ethyl—Pruritus—Thiotepa—urinary bladder cancer	0.000929	0.00138	CcSEcCtD
Icosapent ethyl—Pain—Fluorouracil—urinary bladder cancer	0.000929	0.00138	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—urinary bladder cancer	0.000921	0.00137	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cisplatin—urinary bladder cancer	0.000918	0.00136	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000915	0.00136	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000912	0.00135	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—urinary bladder cancer	0.000912	0.00135	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000911	0.00135	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—urinary bladder cancer	0.000906	0.00134	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—urinary bladder cancer	0.000899	0.00133	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000897	0.00133	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cisplatin—urinary bladder cancer	0.000895	0.00133	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000895	0.00133	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—urinary bladder cancer	0.000894	0.00133	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—urinary bladder cancer	0.000891	0.00132	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000889	0.00132	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—urinary bladder cancer	0.000886	0.00131	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—urinary bladder cancer	0.000886	0.00131	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—urinary bladder cancer	0.000881	0.00131	CcSEcCtD
Icosapent ethyl—Pain—Cisplatin—urinary bladder cancer	0.000881	0.00131	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000878	0.0013	CcSEcCtD
Icosapent ethyl—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000873	0.0013	CcSEcCtD
Icosapent ethyl—Dizziness—Thiotepa—urinary bladder cancer	0.000869	0.00129	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000866	0.00128	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—urinary bladder cancer	0.000861	0.00128	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—urinary bladder cancer	0.000861	0.00128	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—urinary bladder cancer	0.000861	0.00128	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000859	0.00127	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—urinary bladder cancer	0.000849	0.00126	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000849	0.00126	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000844	0.00125	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—urinary bladder cancer	0.000841	0.00125	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000839	0.00124	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000838	0.00124	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—urinary bladder cancer	0.000836	0.00124	CcSEcCtD
Icosapent ethyl—Vomiting—Thiotepa—urinary bladder cancer	0.000835	0.00124	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—urinary bladder cancer	0.000834	0.00124	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—urinary bladder cancer	0.000829	0.00123	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—urinary bladder cancer	0.000829	0.00123	CcSEcCtD
Icosapent ethyl—Rash—Thiotepa—urinary bladder cancer	0.000828	0.00123	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—urinary bladder cancer	0.000828	0.00123	CcSEcCtD
Icosapent ethyl—Dermatitis—Thiotepa—urinary bladder cancer	0.000827	0.00123	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—urinary bladder cancer	0.00082	0.00122	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000815	0.00121	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cisplatin—urinary bladder cancer	0.000814	0.00121	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—urinary bladder cancer	0.000807	0.0012	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—urinary bladder cancer	0.000807	0.0012	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—urinary bladder cancer	0.000795	0.00118	CcSEcCtD
Icosapent ethyl—Asthenia—Gemcitabine—urinary bladder cancer	0.000793	0.00118	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—urinary bladder cancer	0.000789	0.00117	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—urinary bladder cancer	0.000782	0.00116	CcSEcCtD
Icosapent ethyl—Pruritus—Gemcitabine—urinary bladder cancer	0.000782	0.00116	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—urinary bladder cancer	0.000778	0.00115	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—urinary bladder cancer	0.000777	0.00115	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000776	0.00115	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—urinary bladder cancer	0.000772	0.00114	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—urinary bladder cancer	0.000769	0.00114	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000767	0.00114	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—urinary bladder cancer	0.000767	0.00114	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—urinary bladder cancer	0.000746	0.00111	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—urinary bladder cancer	0.000746	0.00111	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—urinary bladder cancer	0.000739	0.0011	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—urinary bladder cancer	0.000739	0.0011	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—urinary bladder cancer	0.000736	0.00109	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—urinary bladder cancer	0.000724	0.00107	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—urinary bladder cancer	0.00072	0.00107	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—urinary bladder cancer	0.000718	0.00107	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—urinary bladder cancer	0.000714	0.00106	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—urinary bladder cancer	0.000703	0.00104	CcSEcCtD
Icosapent ethyl—Vomiting—Gemcitabine—urinary bladder cancer	0.000703	0.00104	CcSEcCtD
Icosapent ethyl—Rash—Gemcitabine—urinary bladder cancer	0.000697	0.00103	CcSEcCtD
Icosapent ethyl—Dermatitis—Gemcitabine—urinary bladder cancer	0.000696	0.00103	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—urinary bladder cancer	0.000692	0.00103	CcSEcCtD
Icosapent ethyl—Vomiting—Fluorouracil—urinary bladder cancer	0.000691	0.00102	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—urinary bladder cancer	0.000691	0.00102	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—urinary bladder cancer	0.000685	0.00102	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—urinary bladder cancer	0.000684	0.00101	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000684	0.00101	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—urinary bladder cancer	0.000678	0.00101	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—urinary bladder cancer	0.000677	0.001	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—urinary bladder cancer	0.00067	0.000993	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—urinary bladder cancer	0.000668	0.000991	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—urinary bladder cancer	0.000668	0.00099	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—urinary bladder cancer	0.000665	0.000986	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—urinary bladder cancer	0.000658	0.000976	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—urinary bladder cancer	0.000655	0.000971	CcSEcCtD
Icosapent ethyl—Rash—Cisplatin—urinary bladder cancer	0.000649	0.000963	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—urinary bladder cancer	0.000649	0.000962	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—urinary bladder cancer	0.000648	0.000961	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000642	0.000953	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—urinary bladder cancer	0.000635	0.000941	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—urinary bladder cancer	0.000627	0.00093	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—urinary bladder cancer	0.000624	0.000926	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—urinary bladder cancer	0.000624	0.000925	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—urinary bladder cancer	0.000622	0.000923	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—urinary bladder cancer	0.000618	0.000917	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000615	0.000913	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—urinary bladder cancer	0.000609	0.000903	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—urinary bladder cancer	0.000604	0.000896	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000601	0.000892	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—urinary bladder cancer	0.0006	0.00089	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—urinary bladder cancer	0.0006	0.000889	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—urinary bladder cancer	0.000595	0.000882	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—urinary bladder cancer	0.000594	0.000881	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—urinary bladder cancer	0.00059	0.000874	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—urinary bladder cancer	0.00059	0.000874	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—urinary bladder cancer	0.00059	0.000874	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000587	0.000871	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—urinary bladder cancer	0.000584	0.000867	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—urinary bladder cancer	0.000582	0.000864	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—urinary bladder cancer	0.000582	0.000863	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—urinary bladder cancer	0.000581	0.000862	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—urinary bladder cancer	0.00058	0.00086	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00057	0.000845	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—urinary bladder cancer	0.000565	0.000839	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000565	0.000838	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—urinary bladder cancer	0.000561	0.000833	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—urinary bladder cancer	0.000559	0.00083	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000556	0.000825	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—urinary bladder cancer	0.000552	0.000818	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—urinary bladder cancer	0.000552	0.000818	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—urinary bladder cancer	0.000552	0.000818	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000546	0.00081	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—urinary bladder cancer	0.000545	0.000808	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—urinary bladder cancer	0.000541	0.000802	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—urinary bladder cancer	0.00054	0.0008	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—urinary bladder cancer	0.000539	0.000799	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—urinary bladder cancer	0.000539	0.000799	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—urinary bladder cancer	0.000538	0.000797	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000529	0.000784	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—urinary bladder cancer	0.000529	0.000784	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000527	0.000782	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—urinary bladder cancer	0.000525	0.000779	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—urinary bladder cancer	0.000523	0.000776	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—urinary bladder cancer	0.00052	0.000772	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—urinary bladder cancer	0.000518	0.000768	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—urinary bladder cancer	0.000516	0.000766	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000515	0.000764	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000511	0.000758	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—urinary bladder cancer	0.000511	0.000758	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—urinary bladder cancer	0.00051	0.000757	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—urinary bladder cancer	0.00051	0.000757	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—urinary bladder cancer	0.00051	0.000757	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—urinary bladder cancer	0.000504	0.000748	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—urinary bladder cancer	0.000504	0.000748	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—urinary bladder cancer	0.000504	0.000747	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—urinary bladder cancer	0.000499	0.00074	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—urinary bladder cancer	0.000497	0.000738	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—urinary bladder cancer	0.000491	0.000729	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000489	0.000726	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—urinary bladder cancer	0.000489	0.000726	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000488	0.000724	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—urinary bladder cancer	0.000486	0.000721	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—urinary bladder cancer	0.000483	0.000717	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000482	0.000715	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—urinary bladder cancer	0.000481	0.000714	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—urinary bladder cancer	0.000478	0.000709	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—urinary bladder cancer	0.000478	0.000708	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000473	0.000702	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—urinary bladder cancer	0.000472	0.000699	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—urinary bladder cancer	0.000466	0.000692	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000466	0.000691	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—urinary bladder cancer	0.000466	0.00069	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—urinary bladder cancer	0.00046	0.000682	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000457	0.000677	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—urinary bladder cancer	0.000452	0.000671	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—urinary bladder cancer	0.000452	0.000671	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—urinary bladder cancer	0.000447	0.000663	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000446	0.000661	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—urinary bladder cancer	0.000443	0.000656	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000436	0.000647	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000436	0.000646	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000431	0.000639	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000425	0.000631	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000422	0.000627	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—urinary bladder cancer	0.000418	0.000621	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—urinary bladder cancer	0.000418	0.000621	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—urinary bladder cancer	0.000418	0.00062	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—urinary bladder cancer	0.000405	0.000601	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000403	0.000598	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—urinary bladder cancer	0.0004	0.000593	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000387	0.000574	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—urinary bladder cancer	0.000379	0.000563	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—urinary bladder cancer	0.000374	0.000555	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—urinary bladder cancer	0.000374	0.000554	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—urinary bladder cancer	0.000359	0.000533	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—urinary bladder cancer	0.000356	0.000528	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—urinary bladder cancer	0.000356	0.000528	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—urinary bladder cancer	0.000351	0.000521	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—urinary bladder cancer	0.00035	0.000519	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—urinary bladder cancer	0.000346	0.000513	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—urinary bladder cancer	0.000336	0.000499	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—urinary bladder cancer	0.000333	0.000495	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—urinary bladder cancer	0.000333	0.000494	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—urinary bladder cancer	0.000324	0.00048	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—urinary bladder cancer	0.000311	0.000461	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—urinary bladder cancer	0.000309	0.000458	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—urinary bladder cancer	0.000308	0.000457	CcSEcCtD
